Addus HomeCare (NASDAQ:ADUS) Price Target Raised to $145.00

Addus HomeCare (NASDAQ:ADUS) had its price target boosted by Stephens from $143.00 to $145.00 in a research report released on Wednesday morning, Benzinga reports. Stephens currently has an overweight rating on the stock.

Several other research analysts have also recently weighed in on ADUS. TD Cowen increased their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Royal Bank of Canada reduced their price target on Addus HomeCare from $141.00 to $136.00 and set an “outperform” rating for the company in a research note on Wednesday. Oppenheimer upped their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. KeyCorp started coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. Finally, Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research note on Monday. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $131.63.

Addus HomeCare Trading Up 5.5 %

ADUS stock opened at $130.96 on Wednesday. Addus HomeCare has a 1-year low of $81.51 and a 1-year high of $136.12. The business’s 50 day simple moving average is $129.75 and its 200 day simple moving average is $120.92. The firm has a market capitalization of $2.37 billion, a PE ratio of 29.97, a PEG ratio of 2.29 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company’s revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.03 earnings per share. As a group, sell-side analysts predict that Addus HomeCare will post 4.57 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares in the company, valued at approximately $429,165. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,917 shares of company stock valued at $3,050,082 over the last quarter. 4.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of Addus HomeCare by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after purchasing an additional 19,027 shares during the last quarter. Point72 Asset Management L.P. boosted its position in Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after buying an additional 315,602 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after buying an additional 5,421 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after buying an additional 75,409 shares in the last quarter. Finally, WCM Investment Management LLC lifted its stake in shares of Addus HomeCare by 2.9% in the 3rd quarter. WCM Investment Management LLC now owns 498,279 shares of the company’s stock valued at $65,250,000 after acquiring an additional 13,938 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.